Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib induction and maintenance study in adults with moderately to severely active ulcerative colitis
MOH_2017-05-08_000370Phase 3Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of filgotinib in autoimmune colitis (3 arms), sponsored by Gilead Sciences. Started Apr 2017; status: active, not recruiting.
02
Drugs
filgotinib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on MOH_2017-05-08_000370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-08_000370.